Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Farinati

Showing results (91-100 of 253) with videos related to

Pageof 26
Sort By:
International Journal of Cancer|March 28, 2008
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphismFabio Farinati, Romilda Cardin, Marina Bortolami, et al.
Cancer|November 9, 2010
Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 studyGiuseppe Lombardi, Fable Zustovich, Fabio Farinati, et al.
Journal of Gastroenterology and Hepatology|March 19, 2014
Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)Caterina Pozzan, Romilda Cardin, Marika Piciocchi, et al.
Plos One|February 26, 2013
Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort studyUmberto Cillo, Alessandro Vitale, Davide Dupuis, et al.
Frontiers in Immunology|August 9, 2022
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to <i>Helicobacter Pylori</i> InfectionFabiana Zingone, Valentina Pilotto, Romilda Cardin, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 20, 2011
MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancerMassimo Negrini, Elena Miotto, Silvia Sabbioni, et al.
BMC Cancer|July 12, 2008
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancerLászló Herszényi, Fabio Farinati, Romilda Cardin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 23, 2014
Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort studyUmberto Cillo, Giulia Noaro, Alessandro Vitale, et al.
Virchows Archiv : an International Journal of Pathology|August 4, 2022
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classesValentina Angerilli, Gianmaria Pennelli, Francesca Galuppini, et al.
Biomedicines|August 27, 2021
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationFilippo Pelizzaro, Romilda Cardin, Anna Sartori, et al.
Pageof 26

Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
International Journal of Cancer|March 28, 2008
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphismFabio Farinati, Romilda Cardin, Marina Bortolami, et al.
Cancer|November 9, 2010
Pegylated liposomal doxorubicin and gemcitabine in patients with advanced hepatocellular carcinoma: results of a phase 2 studyGiuseppe Lombardi, Fable Zustovich, Fabio Farinati, et al.
Journal of Gastroenterology and Hepatology|March 19, 2014
Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC)Caterina Pozzan, Romilda Cardin, Marika Piciocchi, et al.
Plos One|February 26, 2013
Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort studyUmberto Cillo, Alessandro Vitale, Davide Dupuis, et al.
Frontiers in Immunology|August 9, 2022
Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to <i>Helicobacter Pylori</i> InfectionFabiana Zingone, Valentina Pilotto, Romilda Cardin, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 20, 2011
MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancerMassimo Negrini, Elena Miotto, Silvia Sabbioni, et al.
BMC Cancer|July 12, 2008
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancerLászló Herszényi, Fabio Farinati, Romilda Cardin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 23, 2014
Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort studyUmberto Cillo, Giulia Noaro, Alessandro Vitale, et al.
Virchows Archiv : an International Journal of Pathology|August 4, 2022
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classesValentina Angerilli, Gianmaria Pennelli, Francesca Galuppini, et al.
Biomedicines|August 27, 2021
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial ChemoembolizationFilippo Pelizzaro, Romilda Cardin, Anna Sartori, et al.
Pageof 26